DiaMedica Therapeutics Inc. Common Stock

DMAC

...

DMAC: DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.

Show DMAC Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of DMAC by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

No Whale Activity for this ticker

Institutional Holdings Dashboard

Insider Trading

Quarterly net insider trading by DMAC's directors and management

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

No new patents for this ticker

U.S. Patents Dashboard

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on DMAC's company Twitter account

WallStreetBets

Number of mentions of DMAC in WallStreetBets Daily Discussion

DMAC News

Recent insights relating to DMAC

CNBC Recommendations

Recent picks made for DMAC stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in DMAC

Corporate Flights

Flights by private jets registered to DMAC